Abstract
There has been an increase in the prevalence of adults diagnosed with and treated for primary brain tumors. Cognitive deficits are a common long-term effect in brain tumor survivors. The objective of this paper is to examine whether these deficits are specific to those diagnosed with and treated for a primary brain tumor. A systematic review of the medical literature from 2002 to 2012 was conducted to investigate neurocognitive deficits in brain tumor survivors (post-primary treatment) compared to healthy controls. Four studies were identified that met all inclusion criteria. Gliomas were the most common form of tumor included. Neuropsychological evaluation identified cognitive deficits in brain tumor survivors on tests of working memory, cognitive control and flexibility, cognitive processing speed, visual searching, planning and foresight, and general attention. While age, education, and gender can influence cognitive function, the present review indicates that deficits exist beyond those accounted for by these factors. Many primary brain tumor survivors are involved in roles (e.g., employee, parent, spouse/partner, student) that require optimal performance of these cognitive skills. Future research should evaluate brain tumor survivors on functional challenges resulting from these cognitive sequelae and develop effective ways to mitigate them.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Porter K, McCarthy B, Freels S, Kim Y, Davis F (2010) Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol 12(6):520–527. doi:10.1093/neuonc/nop066
Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492–507. doi:10.1056/NEJMra0708126
Kohler B, Ward E, McCarthy B, Schymura M, Ries LA, Eheman C, Jemal A, Anderson R, Ajani U, Edwards B (2011) Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 103(9):714–736
Correa D (2010) Neurocognitive function in brain tumors. Curr Neurol Neurosci Rep 10(3):232–239. doi:10.1007/s11910-010-0108-4
Abrey LE (2012) The impact of chemotherapy on cognitive outcomes in adults with primary brain tumors. J Neurooncol 108(2):285–290
Mortensen EL, Gade A (1993) On the relation between demographic variables and neuropsychological test performance. Scand J Psychol 34(4):305–317. doi:10.1111/j.1467-9450.1993.tb01127.x
van Hooren SA, Valentijn AM, Bosma H, Ponds RW, van Boxtel MP, Jolles J (2007) Cognitive functioning in healthy older adults aged 64–81: a cohort study into the effects of age, sex, and education. Neuropsychol Dev Cogn B 14(1):40–54
Agrigoroaei S, Lachman ME (2011) Cognitive functioning in midlife and old age: combined effects of psychosocial and behavioral factors. J Gerontol B 66(1):130–140
Ganguli M, Snitz BE, Lee CW, Vanderbilt J, Saxton JA, Chang CC (2010) Age and education effects and norms on a cognitive test battery from a population-based cohort: the Monongahela-Youghiogheny Healthy Aging Team. Aging Ment Health 14(1):100–107
Tun PA, Lachman ME (2008) Age differences in reaction time and attention in a national telephone sample of adults: education, sex, and task complexity matter. Dev Psychol 44(5):1421
Wefel J, Schagen S (2012) Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep 12(3):267–275. doi:10.1007/s11910-012-0264-9
Giovagnoli AR (2012) Investigation of cognitive impairments in people with brain tumors. J Neurooncol 108(2):277–283
Scoccianti S, Detti B, Cipressi S, Iannalfi A, Franzese C, Biti G (2012) Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy. J Neurooncol 108(2):291–308
CBTRUS (2012) CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004–2008 (March 23, 2012 Revision)
Aaronson NK, Taphoorn MJ, Heimans JJ, Postma TJ, Gundy CM, Beute GN, Slotman BJ, Klein M (2011) Compromised health-related quality of life in patients with low-grade glioma. J Clin Oncol 29(33):4430–4435. doi:10.1200/JCO.2011.35.5750
Klein M, Heimans J, Aaronson N, van der Ploeg H, Grit J, Muller M, Postma T, Mooij J, Boerman R, Beute G, Ossenkoppele G, van Imhoff G, Dekker A, Jolles J, Slotman B, Struikmans H, Taphoorn M (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360(9343):1361–1368
Godbout L, Grenier MC, Braun CM, Gagnon S (2005) Cognitive structure of executive deficits in patients with frontal lesions performing activities of daily living. Brain Inj 19(5):337–348
Davidson PS, Gao FQ, Mason WP, Winocur G, Anderson ND (2008) Verbal fluency, trail making, and Wisconsin Card Sorting Test performance following right frontal lobe tumor resection. J Clin Exp Neuropsychol 30(1):18–32
Bosma I, Douw L, Bartolomei F, Heimans JJ, van Dijk BW, Postma TJ, Stam CJ, Reijneveld JC, Klein M (2008) Synchronized brain activity and neurocognitive function in patients with low-grade glioma: a magnetoencephalography study. Neuro Oncol 10(5):734–744
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269
Kreutzer J, DeLuca J, Caplan B (eds) (2011) Encyclopedia of clinical neuropsychology, 1st edn. Springer, New York
Lezak M, Howieson D, Loring D (eds) (2004) Neuropsychological assessment, 4th edn. Oxford University Press, New York
Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 14(5):v1–v49
Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenite DG, Aaronson NK, Taphoorn MJ, Baaijen H, Vandertop WP, Muller M, Postma TJ, Heimans JJ (2003) Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54(4):514–520
Feuerstein M, Hansen JA, Calvio LC, Johnson L, Ronquillo JG (2007) Work productivity in brain tumor survivors. J Occup Environ Med 49(7):803–811. doi:10.1097/JOM.0b013e318095a458
Calvio L, Feuerstein M, Hansen J, Luff G (2009) Cognitive limitations in occupationally active malignant brain tumour survivors. Occup Med (Lond) 59(6):406–412. doi:10.1093/occmed/kqp094
Acknowledgements
The authors would like to thank Glenn Pransky, MD, MOcc, William Shaw, PhD, Briana Todd, MA, MS, and Michal Moskowitz, MS for their insightful feedback during the preparation of this article. We are also very thankful for the support of Lennart Dimberg, MD, who kindly arranged for the onsite involvement of medical student Alexander Sonck.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
The opinions and assertions contained in this article are the private views of the authors and are not to be construed as being official or as reflecting the views of the Uniformed Services University of the Health Sciences or the Department of Defense.
Rights and permissions
About this article
Cite this article
Gehrke, A.K., Baisley, M.C., Sonck, A.L.B. et al. Neurocognitive deficits following primary brain tumor treatment: systematic review of a decade of comparative studies. J Neurooncol 115, 135–142 (2013). https://doi.org/10.1007/s11060-013-1215-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-013-1215-2